Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #142
- Final score
- 63.75
- Years on list
- 7
↗ Climbed 177 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 177 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 447 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
Flat trajectory
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | WAT | MRNA | TMO |
|---|---|---|---|
| Climate Change | 75.8 | 79.3 | 72.7 |
| Employee Relations | 58.4 | 61.6 | 56.7 |
| Environment | 63.7 | 47.1 | 61.1 |
| Stakeholders & Society | 79.3 | 76.7 | 63.5 |
| Human Rights | 46.9 | 55.1 | 74.2 |
| Governance | 48.2 | 59.9 | 45.7 |
| Performance Rating | 53.1 | 65.5 | 63.0 |